BinuMalhotraMD

Oncology • Cass City, MI

Physician

Join to view full profile

Dr. Malhotra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Malhotra's full profile

Already have an account?

Office
4675 Hill St
Cass City, MI 48726
Phone+1 989-912-6671

Fax+1 989-912-6030

Education & Training

University of MichiganFellowship, Hematology and Medical Oncology, 2011 - 2014
Cook County Health and Hospitals SystemResidency, Internal Medicine, 2004 - 2007
Lady Hardinge Medical CollegeClass of 2003

Certifications & Licensure

MI State Medical License 2011 - 2027
IL State Medical License 2004 - 2011
IN State Medical License 2010 - 2011
WI State Medical License 2009 - 2011
PA State Medical License 2007 - 2010
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Hematology
American Board of Internal Medicine Medical Oncology

Publications & Presentations

PubMed

2 citations
A Phase II Trial of Pevonedistat and Docetaxel in Patients With Previously Treated Advanced Non-Small-Cell Lung Cancer.
Angel Qin, Leah Wells, Binu Malhotra, Shirish Gadgeel, Bryan J Schneider
Clinical Lung Cancer. 2024-03-01
2 citations
Carboplatin-pemetrexed in treatment of patients with recurrent/metastatic cancers of the head and neck; superior outcomes in oropharyngeal primaries.
Binu Malhotra, Emily Bellile, Nghia Pham Trung Nguyen, Vicki Kay Fung, Matthew Slack
Frontiers in Oncology. 2015-01-26
9 citations
Phase II trial of biweekly gemcitabine and paclitaxel with recurrent or metastatic squamous cell carcinoma of the head and neck: Southwest Oncology Group study S0329.
Binu Malhotra, James C. Moon, Omar Kucuk, Joseph I. Clark, Susan G. Urba
Head & Neck. 2014-12-01